10 Aug 2023
4m
Barclays: Novo Nordisk and Eli Lilly have first-move advantage in the obesity drug race
CNBC Television
Open in Podwise to generate AI notes
Sign in to process this episode and unlock summaries, transcripts, highlights and translations.
Shownotes are not generated by Podwise.